Are Antimotility Agents Safe for Use in <i>Clostridioides difficile</i> Infections? Results From an Observational Study in Malignant Hematology Patients.

Kuon, Carla; Wannier, Rae; Sterken, David; Fang, Margaret C; Wolf, Jeffrey; Prasad, Priya A

Are Antimotility Agents Safe for Use in Clostridioides difficile Infections? Results From an Observational Study in Malignant Hematology Patients.

Kuon, Carla; Wannier, Rae; Sterken, David; Fang, Margaret C; Wolf, Jeffrey; Prasad, Priya A.

Afiliación

Kuon C; Division of Hospital Medicine, University of California, San Francisco, San Francisco.
Wannier R; Division of Hospital Medicine, University of California, San Francisco, San Francisco.
Sterken D; Division of Hospital Medicine, University of California, San Francisco, San Francisco.
Fang MC; Division of Hospital Medicine, University of California, San Francisco, San Francisco.
Wolf J; Division of Hospital Medicine, University of California, San Francisco, San Francisco.
Prasad PA; Division of Hospital Medicine, University of California, San Francisco, San Francisco.

Mayo Clin Proc Innov Qual Outcomes ; 4(6): 792-800, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33367215

Palabras clave

AA, antimotility agent; CDI, Clostridioides difficile infection; EHR, electronic health record; HSCT, hematopoietic stem cell transplant; ICD-10, International Statistical Classification of Diseases, Tenth Revision; ICD-9, International Classification of Diseases, Ninth Revision; IDSA, Infectious Disease Society of America; RR, relative risk; UCSF, University of California, San Francisco

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies Idioma: En Revista: Mayo Clin Proc Innov Qual Outcomes Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google